Additionally, inhibiting LOX enzymes, such as baicalein, has also hindered the pathophysiology of AKI and CKD, reducing neutrophil infiltration and peroxide substrate production and decreasing ferroptosis in CKD [204,205]. This evidence concerns the gene LOX and chronic kidney disease.